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Over the last few decades, the survival of patients with 
systemic lupus erythematosus (SLE) has improved 
dramati  cally. With these patients living longer, medical 
care has moved from merely treating the primary 
condition of the patient to a comprehensive approach 
that includes the provision of preventive services. How 
good we are at providing these services and who is 
responsible for providing them (the specialist as opposed 
to the generalist) have not been previously addressed. 
Lupus-related problems that need to be addressed 
without delay and the limited time allowed per patient 
visit may curtail the ability of the specialist to provide 
such services. But poor communication with the special-
ist may limit the generalist in providing these services, 
particularly if the latter assumes incorrectly that all 
health-related issues (preventive services included) are 
being taken care of by the former. Such assumptions are 
not uncommon in a less-than-ideal and oftentimes frag-
mented health care system, such as the one we currently 
have in the US.
Th  us, it is gratifying to note the study by Yazdany and 
colleagues [1] in this issue of Arthritis Research & Th  erapy. 
In this study on the provision of preventive health services 
to patients with SLE, two categories of preventive services 
were addressed: cancer prevention and immunizations. 
Th  e authors studied patients from the Lupus Outcome 
Study, a longitudinal observational study of more than 
1,000 English-speaking patients recruited from academic 
and non-academic centers and community-based sources 
in Northern California [2]. Data from the California Health 
Interview Survey were used for comparison. Only patients 
for whom a speciﬁ   c service would apply (for example, 
mammography or colon screening) and the respective 
population-based data were included in each of the 
analyses. Patients without health insurance were excluded 
from the analyses. Of interest, the receipt of preventive 
services in the lupus patients was comparable to that of the 
control sample (around 60% for both cancer prevention 
and immunization services). Some interesting factors, 
however, emerged as contributors to lower rates of 
preventive services, speciﬁ   cally younger age and lower 
level of education achieved. In addition, having seen a 
generalist during the preceding year (inﬂ  uenza  and 
pneumococcal immunizations and cervical cancer screen-
ing) as well as the total number of physician visits (cancer 
screening tests) increased the likelihood of receiv  ing 
preventive services. Finally, patients who had a rheuma-
tologist were more likely to receive inﬂ  uenza  immuni-
zations than those who did not have one. In short, even in 
the best circumstances, preventive services are not being 
provided adequately: among lupus patients who speak 
English, are insured, and have a high level of education, 
about one third did not receive the basic preventive 
services evaluated. Th   e data from this population cannot 
be generalized to less fortunate groups of patients with 
SLE: one can only surmise what the rates would be for the 
non-English-speaking, poorly educated, uninsured patients 
with SLE in the US or for patients in developing or 
underdeveloped areas of the world!
As the authors point out in their discussion, lupus 
patients are at increased risk of both infections and 
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Apropos of the article about preventive health care 
for patients with systemic lupus erythematosus in this 
issue of Arthritis Research & Therapy, we off  er some 
thoughts about how best to delineate the roles of 
the specialist (rheumatologist) and the generalist in 
the provision of services to these patients. Even in the 
best circumstances, these services are now provided 
at a rate that is less than optimal. We also off  er a point 
about empowering patients to become vigilant about 
their own care.
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essen  tial if we are to avoid them (infections) or detect 
them early (malignancies). So what should the rheuma-
tologist do? Some changes in our practice need to be 
implemented. Ideally, the changes should be at the 
system level but that may not be possible except for 
contained health care systems (for example, HMOs), in 
which all providers have access to all of a patient’s 
records. Where such access is not possible, reminders in 
the electronic medical records are a viable option. 
Unfortunately, however, many patients receive their care 
outside such systems and thus improvements will require 
a better level of coordination between generalists and 
specialists to delineate who is responsible for providing 
which services and to avoid making baseless assumptions. 
In addition to improved communication, time for 
preventive services should be built into these visits (and 
be considered in the reimbursement process). Eﬀ  orts 
should be made to educate the generalist about the 
importance of these services and to use current guide-
lines to dispel misconceptions that the patient with lupus 
may have about the risks associated with immuni  zations 
[3]. Finally, only patients who are empowered and 
become engaged in their care are likely to remind their 
physicians of the need for preventive services [4]. For 
instance, patients should be encouraged to keep a calen-
dar of preventive tests and take it with them to their 
visits. Th   is is particularly important for those patients at 
higher risk of not obtaining these services: the young and 
the uneducated or less educated. We and others have 
shown that many of the less-than-ideal outcomes that 
patients from minority groups experience (survival and 
damage accrual) [5-8] relate more to lower socio-
economic status (measured as income, poverty level, or 
education level attained) than to ethnicity. Th  is study 
further underscores the importance of socioeconomic 
status in the course of disease and outcome of patients 
with SLE and is a reminder that changes at this level may 
have long-term impact. Th  is study is certainly a call to 
action. Let us respond to this call!
Abbreviation
SLE, systemic lupus erythematosus.
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